Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
46.52M
Dividend Yield
0.00%
P/E Ratio
-2.97
EPS
-11.85
Revenue
128.94M
Avg. Volume
33.83K

Recently from Cashu

publisher logo
Cashu

Atara Biotherapeutics: Overview and Latest Developments in Biopharmaceutical Innovations.

3 days ago
publisher logo
Cashu

Atara Biotherapeutics Boosts T-Cell Immunotherapy with New Hiring and RSU Initiatives

4 months ago
publisher logo
Cashu

Atara Biotherapeutics Under Legal Scrutiny Following FDA Complete Response Letter

5 months ago

About

What does ATRA do?
Atara Biotherapeutics, headquartered in Thousand Oaks, California, is a biotechnology company specializing in allogeneic T-cell immunotherapy, with products like Ebvallo and ATA3219 in various development stages. The company went public on October 16, 2014, and employs 173 staff.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.atarabio.com
Stocks
Health Care
atra
Atara Biotherapeutics
ATRA
-0.06 (-0.75%)
7.96
USD
At close at Jun 20, 20:39 UTC
Summary
News
Signals
Benchmarks
Financials